Catalyst Wire Dossier Catalyst Wire Dossier

Drospirenone/ethinylestradiol 30 µg

drospirenone/ethinylestradiol
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Drospirenone/ethinylestradiol 30 µg, covering 2011-10-25 to 2011-10-25. Get the full timeline:

Most recent: Clinical Trial Update: Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome [NA]

See pricing